Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BRDG, CKPT, QTRX, AKYA on Behalf of Shareholders

CKPT, QTRX, AKYA, BRDG

NEW YORK, NY / ACCESS Newswire / April 19, 2025 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

Bridge Investment Group Holdings Inc. (NYSE:BRDG)'s sale to Apollo. Under the terms of the proposed transaction, Bridge shareholders and Bridge OpCo unitholders will receive, at closing, 0.07081 shares of Apollo stock for each share of Bridge Class A common stock and each Bridge OpCo Class A common unit, respectively. If you are a Bridge shareholder, click here to learn more about your rights and options.

Checkpoint Therapeutics, Inc. (NASDAQ:CKPT)'s sale to Sun Pharmaceutical Industries Limited for $4.10 per share and a contingent value right for up to $0.70 per share on achievement of a milestone. If you are a Checkpoint shareholder, click here to learn more about your rights and options.

Quanterix Corporation (NASDAQ:QTRX)'s merger with Akoya Biosciences, Inc. Upon completion of the proposed transaction, Quanterix shareholders will own approximately 70% of the combined company. If you are a Quanterix shareholder, click here to learn more about your rights and options.

Akoya Biosciences, Inc. (NASDAQ:AKYA)'s sale to Quanterix Corporation for 0.318 shares of Quanterix common stock for each share of Akoya common stock is fair to Akoya shareholders. If you are an Akoya shareholder, click here to learn more about your legal rights and options.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Halper Sadeh LLC
Daniel Sadeh, Esq.
Zachary Halper, Esq.
One World Trade Center
85th Floor
New York, NY 10007
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com
https://www.halpersadeh.com

SOURCE: Halper Sadeh LLP



View the original press release on ACCESS Newswire



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today